search
Back to results

Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy

Primary Purpose

Pelvic Organ Prolapse

Status
Active
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Polyglactin 910 or polydioxanone
Polyester or polypropylene
Sponsored by
Seoul National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pelvic Organ Prolapse

Eligibility Criteria

30 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Anterior vaginal descent beyond the hymen (i.e. POPQ Ba>0)
  • Vaginal bulge symptoms (i.e. an affirmative response to the question 3 from the PFDI-20)
  • Reconstructive surgery is planned

Exclusion Criteria:

  • Recurrent anterior vaginal wall prolapse
  • Reconstructive surgery using mesh or obliterative surgery for prolapse is planned
  • Known pelvic malignancy
  • Systemic glucocorticoid or immunosuppressant treatment
  • Subject wishes to retain her uterus
  • Subject is unable and unwilling to participate in

Sites / Locations

  • Myung Jae, Jeon

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Absorbable suture

Nonabsorbable suture

Arm Description

will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyglactin 910 [Vicryl] or polydioxanone [PDS II] sutures.

will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyester [Ethibond Excel] or polypropylene [Prolene] sutures.

Outcomes

Primary Outcome Measures

Surgical success
defined as the absence of all of the following: (1) anterior vaginal descent beyond the hymen (POPQ point Ba>0); (2) presence of vaginal bulge symptoms (affirmative response to the question 3 from the Pelvic Floor Distress Inventory-20 ("do you usually have a bulge or something falling out that you can see or feel in your vaginal area?"; (3) re-treatment for recurrent anterior vaginal wall prolapse by either surgery or pessary.

Secondary Outcome Measures

The rate of anterior vaginal descent beyond the hymen
POPQ point Ba>0
The rate of vaginal bulge symptoms
an affirmative response to the question 3 from PFDI-20
The rate of re-treatment for recurrent anterior vaginal wall prolapse
by either surgery or pessary
The rate of suboptimal anatomical outcome in each compartment
POPQ point Ba, C, or Bp ≥-1
Change of POPQ values
point Ba, C, Bp and TVL
Change of PFDI-20 scores
The PFDI-20 is a valid and reliable condition-specific quality-of-life questionnaires for women with pelvic floor disorders. It has 20 items and 3 scales (Pelvic Organ Prolapse Distress Inventory, Colorectal-Anal Distress Inventory and Urinary Distress Inventory). Each scale is scored from 0 to 100; higher scores indicate greater symptom burden. The PFDI-20 total score is obtained by adding the scores from the 3 scale scores together (0-300).
The rate of adverse events related with anterior colporrhaphy
intraoperative- bladder injury, ureteral obstruction, massive bleeding postoperative- hematoma, vesico-vaginal fistula, ureteral obstruction, urinary tract infection, incomplete bladder emptying, overactive bladder or stress incontinence symptoms, suture erosion, vaginal wound dehiscence, infection or granulation tissue, etc.

Full Information

First Posted
November 8, 2018
Last Updated
May 26, 2022
Sponsor
Seoul National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03736811
Brief Title
Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy
Official Title
Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 8, 2018 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
June 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The objective of this is to compare surgical outcomes of anterior colporrhaphy using nonabsorbable sutures with anterior colporrhaphy using absorbable sutures.
Detailed Description
This trial is a prospective, randomized trial conducted with the aim to determine superiority of anterior colporrhaphy using nonabsorbable sutures over absorbable sutures with regard to the primary outcome. Participants will undergo reconstructive surgery for prolapse, including anterior colporrhaphy using the assigned suture materials under general or spinal anesthesia. The anterior colporrhaphy will be performed in a traditional manner with midline plication of the fibromuscular layer using either 2-0 nonabsorbable (polyester or polypropylene; Ethicon, Somerville, NJ) or absorbable (polyglactin 910 or polydioxanone; Ethicon) sutures. Concomitant procedures will be performed as intended prior to surgery. Women with a uterus in situ will undergo hysterectomy and all women will receive an apical suspension procedure, including uterosacral ligament suspension, sacrospinous ligament fixation, and iliococcygeal suspension, according to the preference of surgeon. Posterior colporrhaphy and incontinence surgery will also be performed, if indicated (i.e. women with Bp ≥-1 or documented urodynamic stress incontinence). Enrollment, treatment and data collection will be standardized by all sites. The study will be a single-blind study, as it is impossible to blind the study surgeon for the surgical procedure to which the subject in assigned. However, all outcomes assessors and the subjects will be blinded to the treatment assignment. Postoperative follow-up will take place after 5 weeks, 6 months and 12 months. Patients will undergo a standard gynecological examination including POPQ and fill in questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
196 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Absorbable suture
Arm Type
Active Comparator
Arm Description
will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyglactin 910 [Vicryl] or polydioxanone [PDS II] sutures.
Arm Title
Nonabsorbable suture
Arm Type
Experimental
Arm Description
will undergo anterior colporrhaphy in a traditional manner using either 2-0 polyester [Ethibond Excel] or polypropylene [Prolene] sutures.
Intervention Type
Device
Intervention Name(s)
Polyglactin 910 or polydioxanone
Intervention Description
Vicryl or PDS II
Intervention Type
Device
Intervention Name(s)
Polyester or polypropylene
Intervention Description
Ethibond Excel or prolene
Primary Outcome Measure Information:
Title
Surgical success
Description
defined as the absence of all of the following: (1) anterior vaginal descent beyond the hymen (POPQ point Ba>0); (2) presence of vaginal bulge symptoms (affirmative response to the question 3 from the Pelvic Floor Distress Inventory-20 ("do you usually have a bulge or something falling out that you can see or feel in your vaginal area?"; (3) re-treatment for recurrent anterior vaginal wall prolapse by either surgery or pessary.
Time Frame
One year after surgery
Secondary Outcome Measure Information:
Title
The rate of anterior vaginal descent beyond the hymen
Description
POPQ point Ba>0
Time Frame
One year after surgery
Title
The rate of vaginal bulge symptoms
Description
an affirmative response to the question 3 from PFDI-20
Time Frame
One year after surgery
Title
The rate of re-treatment for recurrent anterior vaginal wall prolapse
Description
by either surgery or pessary
Time Frame
One year after surgery
Title
The rate of suboptimal anatomical outcome in each compartment
Description
POPQ point Ba, C, or Bp ≥-1
Time Frame
One year after surgery
Title
Change of POPQ values
Description
point Ba, C, Bp and TVL
Time Frame
From baseline to 1 year after surgery
Title
Change of PFDI-20 scores
Description
The PFDI-20 is a valid and reliable condition-specific quality-of-life questionnaires for women with pelvic floor disorders. It has 20 items and 3 scales (Pelvic Organ Prolapse Distress Inventory, Colorectal-Anal Distress Inventory and Urinary Distress Inventory). Each scale is scored from 0 to 100; higher scores indicate greater symptom burden. The PFDI-20 total score is obtained by adding the scores from the 3 scale scores together (0-300).
Time Frame
From baseline to 1 year after surgery
Title
The rate of adverse events related with anterior colporrhaphy
Description
intraoperative- bladder injury, ureteral obstruction, massive bleeding postoperative- hematoma, vesico-vaginal fistula, ureteral obstruction, urinary tract infection, incomplete bladder emptying, overactive bladder or stress incontinence symptoms, suture erosion, vaginal wound dehiscence, infection or granulation tissue, etc.
Time Frame
From baseline to 1 year after surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Anterior vaginal descent beyond the hymen (i.e. POPQ Ba>0) Vaginal bulge symptoms (i.e. an affirmative response to the question 3 from the PFDI-20) Reconstructive surgery is planned Exclusion Criteria: Recurrent anterior vaginal wall prolapse Reconstructive surgery using mesh or obliterative surgery for prolapse is planned Known pelvic malignancy Systemic glucocorticoid or immunosuppressant treatment Subject wishes to retain her uterus Subject is unable and unwilling to participate in
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Myung Jae Jeon, MD, PhD
Organizational Affiliation
Seoul National University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Myung Jae, Jeon
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32554735
Citation
Jeon MJ, Suh DH, Kim CH, Cho HH, Shin JH, Lee SR, Jung YW, Kim SR, Kong MK. Non-absorbable versus absorbable sutures for anterior colporrhaphy: study protocol for a randomised controlled trial in South Korea. BMJ Open. 2020 Jun 16;10(6):e034218. doi: 10.1136/bmjopen-2019-034218.
Results Reference
derived

Learn more about this trial

Nonabsorbable Versus Absorbable Sutures for Anterior Colporrhaphy

We'll reach out to this number within 24 hrs